Indian Journal of Respiratory Care

IJRC Email      Register      Login

VOLUME 10 , ISSUE 3 ( September-December, 2021 ) > List of Articles


COVID-19 and Lung Cancer: Strengthening the Prevention Component and Improving the Prognosis

Saurabh RamBihariLal Shrivastava, Prateek Saurabh Shrivastava

Keywords : Coronavirus disease-2019 pandemic, lung cancer, World Health Organization

Citation Information : Shrivastava SR, Shrivastava PS. COVID-19 and Lung Cancer: Strengthening the Prevention Component and Improving the Prognosis. Indian J Respir Care 2021; 10 (3):276-279.

DOI: 10.4103/ijrc.ijrc_2_21

License: CC BY-NC-SA 4.0

Published Online: 06-12-2022

Copyright Statement:  Copyright © 2021; Indian Journal of Respiratory Care.


The coronavirus disease-2019 (COVID-19) pandemic overwhelmed health-care delivery systems owing to the significant morbidity and mortality. Lung cancer in the year 2020 alone has accounted for more than 2.2 million new cases and 1.8 million deaths across the globe. The purpose of the current review is to explore the impact of COVID-19 on lung cancer and to identify measures that can improve the prognosis of cancer patients during the ongoing COVID-19 pandemic. An extensive search related to the topic was carried out in the PubMed and World Health Organization website. Relevant research articles focusing on COVID-19 and lung cancer published between April 2020 and June 2021 were included in the review. Forty-five studies similar to the current study objectives were identified initially. Among them, five were excluded due to unavailability of the complete version of the articles. Overall, forty articles were selected based on the suitability with current review objectives. Keywords used in the search include COVID-19 and Lung cancer in the title alone only. It has been estimated that patients with lung cancer will have a significantly higher risk of an adverse outcome, if they acquire COVID-19 infection. National bodies across multiple nations have released recommendations for both prevention and optimal management of COVID-19 infection among known lung cancer patients. To conclude, the COVID-19 pandemic has significantly affected patients with lung cancer. Owing to the emergence of evidence of poor prognosis of infection among lung cancer patients, there is an indispensable need to adopt a multidisciplinary treatment approach.

  1. World Health Organization. Weekly Epidemiological Update on COVID-19 Â- 15 June 2021; 2021. Available from: 15- june-2021. [Last accessed on 2021 Jun 21].
  2. World Health Organization. Cancer - Key Facts; 2021. Available from: [Last accessed on 2021 Jun 21].
  3. Luo J, Rizvi H, Preeshagul IR, Egger JV, Hoyos D, Bandlamudi C, et al. COVID-19 in patients with lung cancer. Ann Oncol 2020;31:1386-96.
  4. Rogado J, Pangua C, Serrano-Montero G, Obispo B, Marino AM, Pérez-Pérez M, et al. Covid-19 and lung cancer: A greater fatality rate? Lung Cancer 2020;146:19-22.
  5. Nie L, Dai K, Wu J, Zhou X, Hu J, Zhang C, et al. Clinical characteristics and risk factors for in-hospital mortality of lung cancer patients with COVID-19: A multicenter, retrospective, cohort study. Thorac Cancer 2021;12:57-65.
  6. Dai MY, Chen Z, Leng Y, Wu M, Liu Y, Zhou F, et al. Patients with lung cancer have high susceptibility of COVID-19: A retrospective study in Wuhan, China. Cancer Control 2020;27:1073274820960467.
  7. Passaro A, Bestvina C, Velez Velez M, Garassino MC, Garon E, Peters S. Severity of COVID-19 in patients with lung cancer: Evidence and challenges. J Immunother Cancer 2021;9:e002266.
  8. Lei H, Yang Y, Zhou W, Zhang M, Shen Y, Tao D, et al. Higher mortality in lung cancer patients with COVID-19? A systematic review and meta-analysis. Lung Cancer 2021;157:60-5.
  9. Garassino MC, Whisenant JG, Huang LC, Trama A, Torri V, Agustoni F, et al. COVID-19 in patients with thoracic malignancies (TERAVOLT): First results of an international, registry-based, cohort study. Lancet Oncol 2020;21:914-22.
  10. Calles A, Aparicio MI, Alva M, Bringas M, Gutierrez N, Soto J, et al. Outcomes of COVID-19 in patients with lung cancer treated in a tertiary hospital in Madrid. Front Oncol 2020;10:1777.
  11. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020;382:1708-20.
  12. Addeo A, Obeid M, Friedlaender A. COVID-19 and lung cancer: Risks, mechanisms and treatment interactions. J Immunother Cancer 2020;8:e000892.
  13. Lung Cancer Study Group, Chinese Thoracic Society; Chinese Medical Association; Chinese Respiratory Oncology Collaboration. Expert recommendations on the management of patients with advanced non-small cell lung cancer during epidemic of coronavirus disease 2019 (Trial version). Zhonghua Jie He He Hu Xi Za Zhi 2020;43:297-301.
  14. Ömeroğlu Şimşek G. Lung cancer management in COVID-19 pandemic. Turk Thorac J 2020;21:340-4.
  15. Van Haren RM, Delman AM, Turner KM, Waits B, Hemingway M, Shah SA, et al. Impact of the COVID-19 pandemic on lung cancer screening program and subsequent lung cancer. J Am Coll Surg 2021;232:600-5.
  16. Leong TL. Delayed access to lung cancer screening and treatment during the COVID-19 pandemic: Are we headed for a lung cancer pandemic? Respirology 2021;26:145-6.
  17. Byrne SC, Jacobson FL, Hammer MM, Dyer DS. Deferral and resumption of lung cancer screening after COVID-19 surge: Patient perspectives from two institutions. J Am Coll Radiol 2021;18:601-4.
  18. Aujayeb A. A note on lung cancer in the COVID-19 era. Respirology 2021;26:510-1.
  19. Passaro A, Peters S, Mok TSK, Attili I, Mitsudomi T, de Marinis F. Testing for COVID-19 in lung cancer patients. Ann Oncol 2020;31:832-4.
  20. Shankar A, Saini D, Bhandari R, Bharati SJ, Kumar S, Yadav G, et al. Lung cancer management challenges amidst COVID-19 pandemic: Hope lives here. Lung Cancer Manag 2020;9:LMT33.
  21. Araujo-Filho JA, Normando PG, Melo MD, Costa AN, Terra RM. Lung cancer in the era of COVID-19: What can we expect? J Bras Pneumol 2020;46:e20200398.
  22. Aran V, De Marchi P, Zamboni M, Ferreira CG. Dealing with lung cancer in the COVID-19 scenario (A review). Mol Clin Oncol 2021;14:27.
  23. Gourd E. Lung cancer control in the UK hit badly by COVID-19 pandemic. Lancet Oncol 2020;21:1559.
  24. Wu L, Zhang C, Zhao X. The impact of COVID-19 pandemic on lung cancer community. World J Oncol 2021;12:1-6.
  25. Sha Z, Chang K, Mi J, Liang Z, Hu L, Long F, et al. The impact of the COVID-19 pandemic on lung cancer patients. Ann Palliat Med 2020;9:3373-8.
  26. Fujita K, Ito T, Saito Z, Kanai O, Nakatani K, Mio T. Impact of COVID-19 pandemic on lung cancer treatment scheduling. Thorac Cancer 2020;11:2983-6.
  27. Baldotto C, Gelatti A, Accioly A, Mathias C, Mascarenhas E, Carvalho H, et al. Lung cancer and the COVID-19 pandemic: Recommendations from the Brazilian Thoracic Oncology Group. Clinics (Sao Paulo) 2020;75:e2060.
  28. Bakhribah H, Zeitouni M, Daghistani RA, Almaghraby HQ, Khankan AA, Alkattan KM, et al. Implications of COVID-19 pandemic on lung cancer management: A multidisciplinary perspective. Crit Rev Oncol Hematol 2020;156:103120.
  29. Calabrò L, Peters S, Soria JC, Di Giacomo AM, Barlesi F, Covre A, et al. Challenges in lung cancer therapy during the COVID-19 pandemic. Lancet Respir Med 2020;8:542-4.
  30. Catania C, Spitaleri G, Del Signore E, Attili I, Radice D, Stati V, et al. Fears and perception of the impact of COVID-19 on patients with lung cancer: A mono-institutional survey. Front Oncol 2020;10:584612.
  31. Albano D, Feraca M, Nemesure B. An assessment of distress levels of patients undergoing lung cancer treatment and surveillance during the COVID-19 pandemic. J Nurse Pract 2021;17:489-91.
  32. Printz C. New guidance for treating patients with lung cancer and COVID-19. Cancer 2020;126:3173.
  33. Wang L, Jiang M, Qu J, Zhou N, Zhang X. Clinical management of lung cancer patients during the outbreak of COVID-19 epidemic. Infect Agent Cancer 2020;15:56.
  34. Singh AP, Berman AT, Marmarelis ME, Haas AR, Feigenberg SJ, Braun J, et al. Management of lung cancer during the COVID-19 pandemic. JCO Oncol Pract 2020;16:579-86.
  35. Xu Y, Liu H, Hu K, Wang M. Clinical recommendations on lung cancer management during the COVID-19 pandemic. Thorac Cancer 2020;11:2067-74.
  36. Wang A, Chang SH, Kim EJ, Bessich JL, Sabari JK, Cooper B, et al. Dynamic management of lung cancer care during surging COVID-19. Front Surg 2021;8:663364.
  37. Haineala B, Zgura A, Badiu DC, Iliescu L, Anghel RM, Bacinschi XE. Lung cancer, COVID-19 infections and chemotherapy. In Vivo 2021;35:1877-80.
  38. Fiorelli S, Massullo D, Ibrahim M, Piccioni F, Andreetti C, Vanni C, et al. Perspectives in surgical and anaesthetic management of lung cancer in the era of coronavirus disease 2019 (COVID-19). Eur J Cardiothorac Surg 2020;58:676-81.
  39. Merritt RE, Kneuertz PJ. Considerations for the surgical management of early stage lung cancer during the COVID-19 pandemic. Clin Lung Cancer 2021;22:156-60.
  40. Lareiro S, Guerra M. COVID-19: Crisis management in lung cancer surgery. Rev Port Cir Cardiotorac Vasc 2020;27:75.
  41. Liao Z, Rivin Del Campo E, Salem A, Pang Q, Liu H, Lopez Guerra JL. Optimizing lung cancer radiation treatment worldwide in COVID-19 outbreak. Lung Cancer 2020;146:230-5.
  42. de Marinis F, Attili I, Morganti S, Stati V, Spitaleri G, Gianoncelli L, et al. Results of multilevel containment measures to better protect lung cancer patients from COVID-19: The IEO model. Front Oncol 2020;10:665.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.